| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |